510(k) K261212
K261212 is an FDA 510(k) premarket notification submitted by ACON Laboratories, Inc. for the device "Flowflex Plus RSV + Flu A/B + COVID Rapid Test". The FDA issued a decision of Substantially Equivalent on July 10, 2026. The device falls under product code SCA (Multi-Analyte Respiratory Virus Antigen Detection Test), a Class II device regulated under 21 CFR 866.3987. ACON Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 10, 2026
- Date Received
- April 14, 2026
- Clearance Type
- Dual Track
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Multi-Analyte Respiratory Virus Antigen Detection Test
- Device Class
- Class II
- Regulation Number
- 866.3987
- Review Panel
- MI
- Submission Type
A multi-analyte respiratory virus antigen detection test is an in vitro diagnostic device intended for the detection and/or differentiation of respiratory viruses directly from respiratory clinical specimens. The device is intended to be performed at the site of sample collection, does not involve sample storage and/or transport.